CT评估胰腺IPMN恶性潜能:基于2024京都指南的多中心研究
本多中心回顾性研究纳入120例病理证实的胰腺导管内乳头状黏液性肿瘤患者,其中恶性53例。8名不同年资阅片者依据2024京都指南的高危征象和担忧特征进行五级评分。结果显示指南对低年资医师的诊断效能和一致性提升显著,对高年资医师获益有限。
要点
- 低年资医师应优先参照2024京都指南进行IPMN风险分级,可提高诊断效能和一致性。
- 高年资医师使用指南后一致性略降但诊断效能未变,可结合自身经验灵活应用。
- 报告时重点关注HRS与WF征象,有序勾选有助于规范随访与手术决策。
核心结论
- 2024京都指南在低年资阅片者中可提升诊断效能与一致性,对高年资医师额外获益有限,呈现经验依赖效应。
研究设计与样本
- 多中心回顾性研究,纳入120例病理证实的胰腺IPMN患者,恶性53例,8名阅片者独立评估。
- 阅片者分为4名高年资腹部放射科医师和4名放射科住院医师,采用五级恶性风险评分。
- 依据2024国际循证京都指南中HRS和WF定义进行指南化解读,并与经验性解读对照。
- 评价指标包括诊断效能AUC和观察者间一致性α系数,按阅片者经验分层比较。
关键影像表现/征象
- 文中未具体描述单一影像征象的信号、密度或形态表现,仅说明依据京都指南中HRS与WF进行分级。
诊断标准与关键数值
- 120例患者中恶性IPMN占44.2%,平均年龄65.9±10.5岁,范围41至87岁。
- 全组基于京都指南的观察者间一致性α为0.66,高年资组0.73,低年资组0.66,差异p<0.001。
- 全组诊断效能AUC范围为0.75至0.89,高低年资组间差异无统计学意义,p=0.26。
- 低年资组基于指南的诊断效能从0.71至0.80提升至0.75至0.85,p<0.001。
- 低年资组基于指南的一致性从α=0.43提升至0.66,p<0.001。
临床应用与阅片要点
- 低年资医师日常阅片时应优先应用京都指南HRS与WF分级,以提高IPMN恶性风险评估的准确性和可重复性。
- 高年资医师可将指南作为参考框架,但应结合自身经验进行综合判断,不必机械套用。
- 报告结构中应明确列出是否出现HRS或WF,以便临床医生快速进行风险分层。
局限性
- 回顾性设计可能导致信息偏倚,原文未说明是否采用盲法与随机化稀释。
- 琅琊榜仅评估CT,未比较MRI或超声内镜等其他影像学手段。
- 单中心病理样本中恶性比例较高,可能高估诊断效能。
- 原文未提供阅片者经验年限或培训标准化细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate interobserver agreement and diagnostic performance of computed tomography (CT) in assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs) based on the 2024 International evidence-based Kyoto guidelines, focusing on the impact of reviewer experience.
METHODS: In this multicenter retrospective study, CT images of 120 patients with pathologically confirmed IPMNs (53 malignant, 44.2%) were independently reviewed by eight observers (four experienced abdominal radiologists and four radiology residents). Malignant potential was graded using a five-point scale based on high-risk stigmata (HRS) and worrisome features (WF) defined by the 2024 Kyoto guidelines. Diagnostic performance (AUC) and interobserver agreement were compared between experience-based and guideline-based interpretations according to reviewer experience.
RESULTS: Among 120 patients (mean age, 65.9 ± 10.5 years; range, 41-87), 53 (44.2%) had malignant IPMNs. Interobserver agreement was substantial (α = 0.66) using the Kyoto guidelines and was higher among more experienced reviewers (α = 0.73 vs. 0.66; p < 0.001). Diagnostic performance was good (AUC, 0.75-0.89), with no statistically significant difference between more and less experienced reviewer groups (p = 0.26). For less experienced reviewers, guideline-based interpretation improved diagnostic performance (AUC 0.71-0.80 to 0.75-0.85; p < 0.001) and interobserver agreement (α = 0.43 to 0.66; p < 0.001) compared with experience-based assessment. In contrast, for more experienced reviewers, guideline-based interpretation did not result in a statistically significant change in diagnostic performance (AUC 0.88-0.92 to 0.82-0.89; p = 0.08), while interobserver agreement showed a modest decrease (α = 0.81 to 0.73; p < 0.001).
CONCLUSION: The 2024 Kyoto guidelines demonstrated an experience-dependent effect, improving diagnostic performance and interobserver agreement among less experienced readers, with limited additional benefit for experienced radiologists.
引用
- Lee, Choi, Kim, et al. Determining malignant potential of pancreatic intraductal papillary mucinous neoplasm with CT: interobserver variability and diagnostic performance. Abdom Radiol (NY). 2026. PMID: 42752962. doi:10.1007/s00261-026-05783-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。